Holen Sie sich die Stockscreener-App
7.71
2.41%
-0.19
Handel nachbörslich:
7.71
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Atara Biotherapeutics Inc (ATRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Atara Biotherapeutics Inc (ATRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Form 13D/A Atara Biotherapeutics For: 24 July By Investing.com - Investing.com South Africa
Form 4 Atara Biotherapeutics Inc For: 24 July By Investing.com - Investing.com South Africa
Atara Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:ATRA - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Shareholders to Connect - ACCESS Newswire
Redmile adjusts Atara Biotherapeutics (ATRA) ownership after warrant exercises - Stock Titan
ATRA|Atara Biotherapeutics Inc|Price:8.040|Chg%:-0.130 - TradingKey
Atara Biotherapeutics Inc (ATRA) Cash Flow - TradingKey
Atara Biotherapeutics Inc (ATRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Price to book forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA - TradingView
Avoiding Lag: Real-Time Signals in (ATRA) Movement - Stock Traders Daily
ATRA|Atara Biotherapeutics Inc|Price:8.089|Chg%:-0.081 - TradingKey
Price to sales forward of Atara Biotherapeutics Inc – SWB:AT20 - TradingView
Price to book forward of Atara Biotherapeutics Inc – SWB:AT20 - TradingView
Enterprise value to revenue forward of Atara Biotherapeutics Inc – SWB:AT20 - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect - ACCESS Newswire
Price to sales forward of Atara Biotherapeutics Inc – TRADEGATE:AT20 - TradingView
Enterprise value to EBITDA forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA - TradingView
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect | NDAQ:ATRA | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biother - The National Law Review
Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewi - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeuti - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
2026-07-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Investors to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse
Enterprise value to EBITDA forward of Atara Biotherapeutics Inc – MUN:AT20 - TradingView
Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Enterprise value to EBIT forward of Atara Biotherapeutics Inc – MUN:AT20 - TradingView
Enterprise value to revenue forward of Atara Biotherapeutics Inc – MUN:AT20 - TradingView
ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - AOL.com
Atara Biotherapeutics Inc. (ATRA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
2026-07-09 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect | NDAQ:ATRA | Press Release - Stockhouse
ATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - AOL.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-07-07 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse
ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Atara Biotherapeutics (ATRA) interim CFO Kevin Sarney files initial Form 3 - Stock Titan
Atara Biotherapeutics (ATRA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Investors to Inquire about Securities Investigation - ACCESS Newswire
Atara Biotherapeutics stock surges on FDA resubmission guidance By Investing.com - Investing.com Nigeria
ATRAAtara Biotherapeutics Inc Latest SEC Filings - Finviz
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Reach Out - ACCESS Newswire
ATRA Stockholders Have Opportunity to Lead Atara Biotherapeutics - The National Law Review
Discipline and Rules-Based Execution in ATRA Response - Stock Traders Daily
ATRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
ATRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Atara Biotherapeutics, Inc.(NasdaqGS:ATRA) dropped from Russell 3000E Value Benchmark - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Connect - ACCESS Newswire
Atara Biotherapeutics Inc Actuals & Estimates (GETTEX:AT20) - TradingView
Atara Biotherapeutics Inc Actuals & Estimates (SWB:AT20) - TradingView
ATRA News | ATARA BIOTHERAPEUTICS INC (NASDAQ:ATRA) - ChartMill
Atara Biotherapeutics (NASDAQ: ATRA) appoints CRCFO consultant as interim CFO - Stock Titan
Atara Biotherapeutics Inc Actuals & Estimates (NASDAQ:ATRA) - TradingView
Atara appoints Kevin G. Sarney as interim CFO; Yanina Grant-Huerta to depart - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):